Business Description
Biostax Corp
NAICS : 325412
SIC : 2834
ISIN : US45252A1079
Description
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -1060.6 | |||||
| Debt-to-Equity | -0.22 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 83.4 | |||||
| 3-Year FCF Growth Rate | 77.1 | |||||
| 3-Year Book Growth Rate | 87 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.75 | |||||
| 9-Day RSI | 21.42 | |||||
| 14-Day RSI | 28.78 | |||||
| 6-1 Month Momentum % | -14.03 | |||||
| 12-1 Month Momentum % | -56.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -459.9 | |||||
| Shareholder Yield % | -22.18 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -722.55 | |||||
| ROIC % | -80.53 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Free-Cash-Flow | 9 | |||||
| Price-to-Operating-Cash-Flow | 9 | |||||
| EV-to-EBIT | -1.38 | |||||
| EV-to-EBITDA | -1.39 | |||||
| EV-to-FCF | 19.69 | |||||
| Earnings Yield (Greenblatt) % | -72.46 | |||||
| FCF Yield % | 9.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BTAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biostax Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.029 | ||
| Beta | 0.3 | ||
| Volatility % | 105.55 | ||
| 14-Day RSI | 28.78 | ||
| 14-Day ATR ($) | 0.001286 | ||
| 20-Day SMA ($) | 0.02102 | ||
| 12-1 Month Momentum % | -56.41 | ||
| 52-Week Range ($) | 0.018 - 0.15 | ||
| Shares Outstanding (Mil) | 83.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biostax Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biostax Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biostax Corp Frequently Asked Questions
What is Biostax Corp(BTAX)'s stock price today?
The current price of BTAX is $0.02. The 52 week high of BTAX is $0.15 and 52 week low is $0.02.
When is next earnings date of Biostax Corp(BTAX)?
The next earnings date of Biostax Corp(BTAX) is 2024-12-26 Est..
Does Biostax Corp(BTAX) pay dividends? If so, how much?
Biostax Corp(BTAX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers